DUBLIN, Feb. 28, 2020 /PRNewswire/ -- The "Protein Sequencing Market by Product and Service Technology and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
According to the report, the global protein sequencing market is expected to reach $9,926.7 million by 2026, registering a CAGR of 7.8% from 2019 to 2026, in terms of value.
Surge in focus toward target-based drug development by pharmaceutical and biotechnology companies is the major factor anticipated to drive the protein sequencing market growth. Further, advancements in clinical mass spectrometry & analytical techniques and rise in public-private financial support for proteomic research propels the market growth in the near future.
However, the uptake of protein sequencing method is constrained by the high cost of infrastructures and equipment, such as that of mass spectrometers.In addition, dearth of skilled researchers and laboratory professionals are also the major factors hampering the market growth.
On the contrary, technological advancements for the identification of isobaric residues in protein sequences are expected to create lucrative opportunities and thus, generating new protein sequencing market trends in near future.
Based on technology, the Edman degradation segment accounted for 58% share in the protein sequencing market in 2018. This segment is expected to exhibit a prominent growth rate, owing to its wide usage for protein sequencing. However, mass spectrometry is anticipated to grow at the fastest growth rate during the forecast period. This is attributed to its fast, precise, accurate protein sequencing ability. The technique can even sequence large peptide sequences that too in lesser time than Edman degradation.
Based on protein sequencing market analysis, by application, the biopharmaceuticals segment dominated the protein sequencing market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased research toward the development of protein-based innovative and novel biotherapeutics for treatment of various diseases. The usage of protein sequencing for development of biopharmaceuticals in the new and potent are of research that is anticipated to create lucrative opportunities in the near future.
Key Findings
- By product & service, the reagent & consumables segment accounted for the highest market share of 57% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
- By region, North America was the major shareholder and accounted for the highest share of 40% in 2018.
- By application, the biopharmaceuticals segment is expected to grow at a CAGR of 8.5% during the forecast period.
- By end user, the biotechnology & pharmaceutical company segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.
Topics Covered
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Porter's Five Forces Analysis
3.3. Market Share Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increasing Focus on Target-Based Drug Development
3.4.1.2. Advancements in Mass Spectrometry and Analytical Techniques
3.4.2. Restraints
3.4.2.1. Dearth of Skilled Researchers and Laboratory Professionals
3.4.3. Opportunities
3.4.3.1. Opportunity in Computational Proteomics
Chapter 4: Protein Sequencing Market, By Products & Services
4.1. Overview
4.2. Reagents & Consumables
4.3. Instruments
4.4. Analysis Product
4.5. Protein Sequencing Services
Chapter 5: Protein Sequencing Market, By Technology
5.1. Overview
5.2. Mass Spectrometry
5.3. Edman Degradation
Chapter 6: Protein Sequencing Market, By Application
6.1. Overview
6.2. Biopharmaceuticals
6.3. Biotechnology Research
Chapter 7: Protein Sequencing Market By Region
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia-Pacific
7.5. LAMEA
Chapter 8: Company Profiles
8.1. Charles River Laboratories
8.2. Shimadzu Corp.
8.3. Agilent Technologies (USA)
8.4. Thermo Fischer Inc.
8.5. Selvita (SA)
8.6. Rapid Novor.
8.7. SGS (SA)
8.8. Proteome Factory
8.9. Bioinformatics Solution
8.10. Water Corporation
For more information about this report visit https://www.researchandmarkets.com/r/b29uam
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
